Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: PR Newswire
PISCATAWAY, N.J., Oct. 16, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading scientists, industry experts, investors, and regulatory authorities at the GenScript Biotech Global Forum. This series of conferences aims to address key industrial trends in cell therapy and gene therapy.In the coming months, GenScript Biotech Global Forum will take place in London during the Jefferies London Healthcare Conference on November 20, 2024 and at JP Morgan Healthcare Conference in San Francisco on January 15, 2025For more information, please visit the London forum website or check the Preliminary Agenda.Register Now: https://bit.ly/477v0paRegister using code GS2024 to reserve your free pass (limited to 20 tickets only).Highlights from the GenScript Biotech Global Forum London 2024Sch
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy DevelopmentPR Newswire
- Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]Yahoo! Finance
- Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $73.00 price target on the stock.MarketBeat
- Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]Yahoo! Finance
LEGN
Earnings
- 5/13/24 - Beat
LEGN
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form S-8
- 11/12/24 - Form SC
- LEGN's page on the SEC website